Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandor Kantor

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Neuropharmacology|January 26, 2016
A single dose of hypnotic corrects sleep and EEG abnormalities in symptomatic Huntington's disease miceSandor Kantor, Janos Varga, A Jennifer Morton
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 28, 2017
Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease MiceSandor Kantor, Janos Varga, Shreya Kulkarni, et al.
British Journal of Pharmacology|July 22, 2004
Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505Sandor Kantor, Rita Jakus, Brigitta Balogh, et al.
Brain Research|June 29, 2002
Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shiftSandor Kantor, Rita Jakus, Robert Bodizs, et al.
Neuroscience Letters|March 31, 2004
Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsyMarton Graf, Rita Jakus, Sandor Kantor, et al.
Brain : a Journal of Neurology|June 27, 2013
Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutationSandor Kantor, Lajos Szabo, Janos Varga, et al.
Behavioural Brain Research|June 12, 2003
m-CPP-induced self-grooming is mediated by 5-HT2C receptorsMarton Graf, Sandor Kantor, Zsuzsanna E Anheuer, et al.
Brain Research|July 22, 2008
MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibitionNorbert Gyongyosi, Brigitta Balogh, Eszter Kirilly, et al.
Psychopharmacology|September 17, 2013
Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in miceJozsef Haller, Mano Aliczki, Katalin Gyimesine Pelczer, et al.
Sleep|September 16, 2009
Orexin neurons are necessary for the circadian control of REM sleepSandor Kantor, Takatoshi Mochizuki, Agnieszka M Janisiewicz, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Neuropharmacology|January 26, 2016
A single dose of hypnotic corrects sleep and EEG abnormalities in symptomatic Huntington's disease miceSandor Kantor, Janos Varga, A Jennifer Morton
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 28, 2017
Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease MiceSandor Kantor, Janos Varga, Shreya Kulkarni, et al.
British Journal of Pharmacology|July 22, 2004
Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505Sandor Kantor, Rita Jakus, Brigitta Balogh, et al.
Brain Research|June 29, 2002
Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shiftSandor Kantor, Rita Jakus, Robert Bodizs, et al.
Neuroscience Letters|March 31, 2004
Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsyMarton Graf, Rita Jakus, Sandor Kantor, et al.
Brain : a Journal of Neurology|June 27, 2013
Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutationSandor Kantor, Lajos Szabo, Janos Varga, et al.
Behavioural Brain Research|June 12, 2003
m-CPP-induced self-grooming is mediated by 5-HT2C receptorsMarton Graf, Sandor Kantor, Zsuzsanna E Anheuer, et al.
Brain Research|July 22, 2008
MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibitionNorbert Gyongyosi, Brigitta Balogh, Eszter Kirilly, et al.
Psychopharmacology|September 17, 2013
Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in miceJozsef Haller, Mano Aliczki, Katalin Gyimesine Pelczer, et al.
Sleep|September 16, 2009
Orexin neurons are necessary for the circadian control of REM sleepSandor Kantor, Takatoshi Mochizuki, Agnieszka M Janisiewicz, et al.
Pageof 2